Ardent Health (NYSE:ARDT) Releases FY 2026 Earnings Guidance

Ardent Health (NYSE:ARDT) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.780-1.150 for the period, compared to the consensus estimate of 1.220. The company issued revenue guidance of $6.4 billion-$6.7 billion, compared to the consensus revenue estimate of $6.5 billion.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Wall Street Zen downgraded Ardent Health from a “buy” rating to a “hold” rating in a research note on Sunday, July 12th. Royal Bank Of Canada reduced their target price on Ardent Health from $13.00 to $12.00 and set an “outperform” rating for the company in a research report on Thursday, July 9th. Truist Financial increased their price objective on shares of Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a research note on Thursday. The Goldman Sachs Group reiterated a “neutral” rating and set a $13.00 target price on shares of Ardent Health in a research report on Thursday. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Ardent Health in a research report on Friday, June 12th. Seven analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, Ardent Health presently has an average rating of “Hold” and an average target price of $13.54.

Ardent Health Price Performance

Shares of ARDT stock remained flat at $11.16 during trading hours on Thursday. 211,489 shares of the stock were exchanged, compared to its average volume of 463,826. Ardent Health has a 12 month low of $7.71 and a 12 month high of $15.48. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.00 and a current ratio of 2.12. The business has a fifty day moving average price of $9.89 and a two-hundred day moving average price of $9.46. The firm has a market cap of $1.60 billion, a P/E ratio of 20.30, a price-to-earnings-growth ratio of 2.53 and a beta of 0.70.

Ardent Health (NYSE:ARDT) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). Ardent Health had a net margin of 1.22% and a return on equity of 10.45%. The company had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, research analysts anticipate that Ardent Health will post 1.06 earnings per share for the current year.

Insider Buying and Selling at Ardent Health

In other news, CFO Alfred Lumsdaine bought 10,000 shares of the company’s stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $8.81 per share, for a total transaction of $88,100.00. Following the completion of the transaction, the chief financial officer directly owned 329,183 shares in the company, valued at $2,900,102.23. The trade was a 3.13% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.90% of the stock is currently owned by insiders.

Institutional Trading of Ardent Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in ARDT. Caitong International Asset Management Co. Ltd increased its stake in shares of Ardent Health by 1,177.7% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after acquiring an additional 2,638 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in Ardent Health during the third quarter worth about $61,000. New York State Common Retirement Fund grew its stake in Ardent Health by 121.4% in the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after acquiring an additional 3,400 shares during the period. Squarepoint Ops LLC acquired a new position in Ardent Health in the third quarter valued at about $145,000. Finally, Fox Run Management L.L.C. bought a new stake in shares of Ardent Health in the fourth quarter worth about $147,000.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.